GTS Securities LLC decreased its holdings in Ventas, Inc. (NYSE:VTR – Free Report) by 51.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,221 shares of the real estate investment trust’s stock after selling 6,721 shares during the period. GTS Securities LLC’s holdings in Ventas were worth $552,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Dynamic Wealth Strategies LLC purchased a new stake in Ventas during the 1st quarter worth about $25,000. Wiser Advisor Group LLC acquired a new stake in Ventas in the 3rd quarter valued at about $27,000. Silvant Capital Management LLC purchased a new position in shares of Ventas in the 2nd quarter valued at about $28,000. Meeder Asset Management Inc. purchased a new position in shares of Ventas in the 2nd quarter valued at about $30,000. Finally, IFC & Insurance Marketing Inc. acquired a new position in shares of Ventas during the fourth quarter worth about $30,000. 94.18% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Ventas
In related news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.53% of the company’s stock.
Ventas Trading Down 0.0%
Ventas (NYSE:VTR – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 earnings per share. As a group, equities research analysts expect that Ventas, Inc. will post 3.89 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on VTR. The Goldman Sachs Group restated a “buy” rating and set a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Jefferies Financial Group lifted their price target on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. UBS Group raised their price objective on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $100.00 price objective on shares of Ventas in a research report on Tuesday, June 16th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and an average target price of $98.00.
Get Our Latest Stock Analysis on VTR
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
